Titel

Merkliste
1 Ergebnisse

Indacaterol/glycopyrronium reduces the risk of clinically i..:

Greulich T ; Kostikas K ; Gaga M...
https://www.dovepress.com/indacaterolglycopyrronium-reduces-the-risk-of-clinically-important-det-peer-reviewed-article-COPD. , 2018

Link: https://doaj.org/article/98ab3981b4044527b72f9f136e561..

RT Journal
T1 <Title>Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:98ab3981b4044527b72f9f136e561e85&Exemplar=1&LAN=DE
				
A1 Greulich T
A1 Kostikas K
A1 Gaga M
A1 Aalamian-Mattheis M
A1 Lossi NS
A1 Patalano F
A1 Nunez X
A1 Pagano VA
A1 Fogel R
A1 Vogelmeier CF
A1 Clemens A
PB Dove Medical Press
YR 2018
K1 Clinically Important Deterioration/CID
K1 indacaterol/glycopyrronium
K1 COPD Risk Reduction
K1 Open-label
K1 Clinical COPD Questionnaire/CCQ
K1 transition dyspnea index/TDI
K1 Diseases of the respiratory system
K1 RC705-779
JF https://www.dovepress.com/indacaterolglycopyrronium-reduces-the-risk-of-clinically-important-det-peer-reviewed-article-COPD
LK http://dx.doi.org/https://doaj.org/article/98ab3981b4044527b72f9f136e561e85
DO https://doaj.org/article/98ab3981b4044527b72f9f136e561e85
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)